Xenazine Tablet
Product Images NDC 67386-421

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Xenazine (NDC 67386-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lundbeck Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xenazine Tetrabenazine Tablet 1

FDA Label Image

Xenazine Tetrabenazine Tablet 2

This is a graph depicting the Chorea Score Change for Placebo and XENAZINE WashoulI. The study took place for 13 weeks, and the error bars represent the standard error of the mean. The asterisk indicates that p-value is less than 0.05, which suggests significant differences between the two groups.*

FDA Label Image

Xenazine Tetrabenazine Tablet 3

FDA Label Image

Xenazine Tetrabenazine Tablet 4

FDA Label Image

Xenazine Tetrabenazine Tablet 5

Xenazine(tetrabenazine) Tablets are dispensed to each patient. The tablets contain bz, m. Each tablet has a usual dosage of S0 compayng pckage mat. For more information, visit www.xenazineusa.com.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.